Hanon Systems (018880.KS), an automotive thermal management solutions company, on Thursday reported higher operating income in the third quarter of 2026 compared with the previous year.
For the third quarter, net income attributable to shareholders of parent company came in at KRW 143.02 billion compared with net income of KRW 54.67 billion in the previous year.
Operating income increased to KRW 120.61 billion from KRW 95.30 billion in the prior year.
Sales increased to KRW 2.66 trillion from KRW 2.71 trillion in the previous year.
On Wednesday, Hanon Systems is currently trading 4.01% lesser at KRW 3,355 on the Korean Stock Exchange.
For comments and feedback contact: [email protected]
Business News
November 03, 2026 10:34 ET A key date in rare disease research. BridgeBio Pharma’s BBP-418 is under FDA Priority Review for limb-girdle muscular dystrophy type 2I/R9, a rare genetic disease with no approved treatment. The FDA decision is targeted for November 27. If approved, BBP-418 could become the first approved therapy for any form of limb-girdle muscular dystrophy.